ILLUMINA, INC. — Director's Dealing 2015

Dec 14, 2015

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ILLUMINA INC (ILMN)
CIK: 0001110803
Period of Report: 2015-12-07

Reporting Person: ORPIN TRISTAN (EVP Clinical Genomics)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	99427	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Non-qualified Stock Option (Right to Buy)	$37.04	2020-01-27	Common Stock (35000)		Direct
Non-qualified Stock Option (Right to Buy)	$69.34	2021-01-31	Common Stock (5000)		Direct

Footnotes

F1: Includes 38,955 unvested performance stock units, which represent contingent right to receive one share of common stock based on the Company's earnings per share for fiscal years ending 1/3/16 (24,000 shares), 1/1/17 (8,438 shares), 12/31/17 (6,517 shares). Number of shares issued will range from 0% to 150% of the amount specified based on the Company's actual earnings per share for each fiscal year, relative to pre-defined objectives.

F2: Includes 7,716 unvested restricted stock units which vest as follows: 2,036 vesting 1/29/16, 1,312 vesting 3/8/16, 543 vesting 11/5/16, 2,036 vesting 1/29/17, 543 vesting 11/5/17, 703 vesting 1/29/18, 543 vesting 11/5/18.

F3: One forty-eighth (1/48) of the Shares subject to the Option become exercisable on the date indicated above, subject to Optionee's continuing to be a Service Provider on such date. An additional one-forty eighth (1/48) of the Shares subject to the Option shall become exercisable each full month therafter, subject to Optionee's continuing to be a Service Provider on such date.